| SARS-CoV-2 variants B. 1.351 and P. 1 escape from neutralizing antibodies M Hoffmann, P Arora, R Groß, A Seidel, BF Hörnich, AS Hahn, N Krüger, ... Cell 184 (9), 2384-2393. e12, 2021 | 1017 | 2021 |
| Semen-derived amyloid fibrils drastically enhance HIV infection J Münch, E Rücker, L Ständker, K Adermann, C Goffinet, M Schindler, ... Cell 131 (6), 1059-1071, 2007 | 655 | 2007 |
| Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation SA Sievers, J Karanicolas, HW Chang, A Zhao, L Jiang, O Zirafi, ... Nature 475 (7354), 96-100, 2011 | 543 | 2011 |
| SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas JA Müller, R Groß, C Conzelmann, J Krüger, U Merle, J Steinhart, T Weil, ... Nature metabolism 3 (2), 149-165, 2021 | 542 | 2021 |
| Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains D Sauter, M Schindler, A Specht, WN Landford, J Münch, KA Kim, ... Cell host & microbe 6 (5), 409-421, 2009 | 521 | 2009 |
| Detection of SARS-CoV-2 in human breastmilk R Groß, C Conzelmann, JA Müller, S Stenger, K Steinhart, F Kirchhoff, ... The Lancet 395 (10239), 1757-1758, 2020 | 505 | 2020 |
| Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1 M Schindler, J Münch, O Kutsch, H Li, ML Santiago, F Bibollet-Ruche, ... Cell 125 (6), 1055-1067, 2006 | 501 | 2006 |
| Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination J Barros-Martins, SI Hammerschmidt, A Cossmann, I Odak, MV Stankov, ... Nature medicine 27 (9), 1525-1529, 2021 | 442 | 2021 |
| Nef proteins from simian immunodeficiency viruses are tetherin antagonists F Zhang, SJ Wilson, WC Landford, B Virgen, D Gregory, MC Johnson, ... Cell host & microbe 6 (1), 54-67, 2009 | 427 | 2009 |
| TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition MA Mandell, A Jain, J Arko-Mensah, S Chauhan, T Kimura, C Dinkins, ... Developmental cell 30 (4), 394-409, 2014 | 357 | 2014 |
| Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide J Münch, L Ständker, K Adermann, A Schulz, M Schindler, R Chinnadurai, ... Cell 129 (2), 263-275, 2007 | 349 | 2007 |
| DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus S Pöhlmann, F Baribaud, B Lee, GJ Leslie, MD Sanchez, ... Journal of virology 75 (10), 4664-4672, 2001 | 298 | 2001 |
| Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection S Wildum, M Schindler, J Münch, F Kirchhoff Journal of virology 80 (16), 8047-8059, 2006 | 280 | 2006 |
| LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus T Gramberg, H Hofmann, P Möller, PF Lalor, A Marzi, M Geier, ... Virology 340 (2), 224-236, 2005 | 255 | 2005 |
| Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte L Ding, J Münch, H Goerls, A Maier, HH Fiebig, WH Lin, C Hertweck Bioorganic & medicinal chemistry letters 20 (22), 6685-6687, 2010 | 254 | 2010 |
| Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2 TL Meister, Y Brüggemann, D Todt, C Conzelmann, JA Müller, R Groß, ... The Journal of infectious diseases 222 (8), 1289-1292, 2020 | 237 | 2020 |
| Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and … M Schindler, S Würfl, P Benaroch, TC Greenough, R Daniels, ... Journal of virology 77 (19), 10548-10556, 2003 | 231 | 2003 |
| Low levels of SIV infection in sooty mangabey central memory CD4+ T cells are associated with limited CCR5 expression M Paiardini, B Cervasi, E Reyes-Aviles, L Micci, AM Ortiz, A Chahroudi, ... Nature medicine 17 (7), 830-836, 2011 | 230 | 2011 |
| Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities M Hayn, M Hirschenberger, L Koepke, R Nchioua, JH Straub, S Klute, ... Cell reports 35 (7), 2021 | 229 | 2021 |
| The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection NR Roan, J Münch, N Arhel, W Mothes, J Neidleman, A Kobayashi, ... Journal of virology 83 (1), 73-80, 2009 | 229 | 2009 |
Frank KirchhoffUniversity of UlmBestätigte E-Mail-Adresse bei uni-ulm.de